Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Ultra-Orthodox protests erupt across Israel on haredi IDF enlistment day - 2Ancient mass grave discovered in water cistern during Tel Azekah excavations
- 3Starship success, a private moon landing and more: The top 10 spaceflight stories of 2025
- 4Find the Advantages of Innovative Leisure activities: Supporting Creative mind and Self-Articulation
- 57 Fun Plans to Make Film Evenings Seriously Energizing (You'll Cherish #5!)
- Elvis Presley's Infamous Pantera Shooting
- Netflix's Eddie Murphy documentary explains 'Saturday Night Live' beef: 'That's why I didn't go back for years'
- Ukraine demands army of 800,000 under peace plan
- Zelensky names spy chief to head presidential office after corruption row
- Most normal matter in the universe isn't found in planets, stars or galaxies – an astronomer explains where it's distributed
- Thousands of genomes reveal the wild wolf genes in most dogs’ DNA
- PA accuses Israel of 'human trafficking' after planeload of Gazans arrives in South Africa
- Humanity is back at the moon! Artemis 2 astronauts arrive in lunar space
- German finance minister sees advantages of smartphones in schools
